RU2403013C2 - Твердая дисперсия, содержащая активный ингредиент с низкой температурой плавления, и содержащая ее таблетка для перорального введения - Google Patents

Твердая дисперсия, содержащая активный ингредиент с низкой температурой плавления, и содержащая ее таблетка для перорального введения Download PDF

Info

Publication number
RU2403013C2
RU2403013C2 RU2008129041/15A RU2008129041A RU2403013C2 RU 2403013 C2 RU2403013 C2 RU 2403013C2 RU 2008129041/15 A RU2008129041/15 A RU 2008129041/15A RU 2008129041 A RU2008129041 A RU 2008129041A RU 2403013 C2 RU2403013 C2 RU 2403013C2
Authority
RU
Russia
Prior art keywords
tablet
solid dispersion
pharmaceutically acceptable
release
fused solid
Prior art date
Application number
RU2008129041/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2008129041A (ru
Inventor
Дзонг Соо ВОО (KR)
Дзонг Соо Воо
Санг Воок КИМ (KR)
Санг Воок КИМ
Хонг Ги ЙИ (KR)
Хонг Ги Йи
Дзае Кук РИУ (KR)
Дзае Кук РИУ
Original Assignee
Ханми Фарм. Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ханми Фарм. Ко., Лтд. filed Critical Ханми Фарм. Ко., Лтд.
Publication of RU2008129041A publication Critical patent/RU2008129041A/ru
Application granted granted Critical
Publication of RU2403013C2 publication Critical patent/RU2403013C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2008129041/15A 2005-12-16 2006-12-18 Твердая дисперсия, содержащая активный ингредиент с низкой температурой плавления, и содержащая ее таблетка для перорального введения RU2403013C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2005-0124386 2005-12-16
KR20050124386 2005-12-16

Publications (2)

Publication Number Publication Date
RU2008129041A RU2008129041A (ru) 2010-01-27
RU2403013C2 true RU2403013C2 (ru) 2010-11-10

Family

ID=38163142

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008129041/15A RU2403013C2 (ru) 2005-12-16 2006-12-18 Твердая дисперсия, содержащая активный ингредиент с низкой температурой плавления, и содержащая ее таблетка для перорального введения

Country Status (14)

Country Link
US (1) US20080292702A1 (enExample)
EP (1) EP1968542B1 (enExample)
JP (1) JP2009519326A (enExample)
CN (1) CN101330904B (enExample)
AU (1) AU2006325658B2 (enExample)
BR (1) BRPI0619868A8 (enExample)
CA (1) CA2633266C (enExample)
ES (1) ES2429097T3 (enExample)
IL (1) IL191804A0 (enExample)
NO (1) NO339674B1 (enExample)
NZ (1) NZ569813A (enExample)
RU (1) RU2403013C2 (enExample)
WO (1) WO2007069874A1 (enExample)
ZA (1) ZA200806138B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2685294C1 (ru) * 2018-05-10 2019-04-17 Общество с ограниченной ответственностью "ДИНОН" (ООО "ДИНОН") Поглотитель, способ его приготовления (варианты) и способ удаления диоксида углерода из газовых смесей

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06002731A (es) 2003-09-11 2006-06-05 Xenoport Inc Tratamiento y/o prevencion de incontinencia urinaria utilizando profarmacos de analogos de gaba.
KR101005391B1 (ko) * 2008-07-22 2010-12-30 한국콜마 주식회사 덱시부프로펜 함유 서방출성 시럽제 및 그의 제조방법
KR101067224B1 (ko) * 2008-07-22 2011-09-22 한국콜마 주식회사 이부프로펜 함유 서방출성 시럽제 및 그의 제조방법
CN101961306B (zh) * 2009-07-24 2011-11-09 北京化工大学 一种低熔点药物固体分散体的制备方法
CN102144982B (zh) * 2011-03-30 2012-12-12 江苏神龙药业有限公司 一种米诺膦酸片及其制备方法
CN102406940B (zh) * 2011-11-01 2013-07-03 温州大学 一种纳米级片状羧甲基淀粉钠在固体分散体中的应用
WO2013154511A1 (en) * 2012-04-13 2013-10-17 Mahmut Bilgic Film tablet formulations comprising dexibuprofen
UY36046A (es) 2014-03-26 2015-10-30 Millennium Pharm Inc Formulaciones farmacéuticas, procesos para la preparación y métodos de uso
JP6647902B2 (ja) * 2015-10-30 2020-02-14 株式会社ファンケル 徐放性顆粒剤
CN106265522A (zh) * 2016-08-30 2017-01-04 铜陵翔宇商贸有限公司 布洛芬‑pvp共沉淀物及其制备方法
JP7147262B2 (ja) * 2017-05-23 2022-10-05 大正製薬株式会社 固形製剤
JP7109255B2 (ja) * 2017-05-23 2022-07-29 ライオン株式会社 粉砕物の製造方法及び錠剤の製造方法
EP3658123A4 (en) * 2017-07-24 2021-04-28 Acryspharm LLC PHARMACEUTICAL COMPOSITIONS WITH A HIGH DRUG LOAD
CN112263567B (zh) * 2020-10-19 2022-05-03 南京易亨制药有限公司 一种布洛芬缓释胶囊及制备方法
CN117363320B (zh) * 2023-12-07 2024-02-13 黑龙江省鑫博鑫交通科技有限公司 一种公路用融雪剂及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2197228C2 (ru) * 1995-09-29 2003-01-27 Басф Аг Твердые лекарственные формы, получаемые экструзией содержащего изомальт расплава полимера и активного вещества
RU2246294C2 (ru) * 1999-12-09 2005-02-20 Дзе Бутс Компани ПЛС Терапевтические средства

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56120616A (en) * 1980-02-27 1981-09-22 Kaken Pharmaceut Co Ltd Ibuprofen-containing granule, its preparation, and internal medicine comprising it
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
CH669523A5 (enExample) * 1986-06-25 1989-03-31 Mepha Ag
US4806359A (en) * 1987-04-22 1989-02-21 Mcneilab, Inc. Iburprofen sustained release matrix and process
DE19509807A1 (de) * 1995-03-21 1996-09-26 Basf Ag Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs
US6391338B1 (en) * 1995-09-07 2002-05-21 Biovail Technologies Ltd. System for rendering substantially non-dissoluble bio-affecting agents bio-available
DE69739165D1 (de) * 1996-07-08 2009-01-29 Penwest Pharmaceuticals Co Matrix mit verzögerter freisetzung für hochdosierte unlösliche arzneistoffe
US6787157B1 (en) * 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
US6183779B1 (en) * 1999-03-22 2001-02-06 Pharmascience Inc. Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
GB0113839D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2197228C2 (ru) * 1995-09-29 2003-01-27 Басф Аг Твердые лекарственные формы, получаемые экструзией содержащего изомальт расплава полимера и активного вещества
RU2246294C2 (ru) * 1999-12-09 2005-02-20 Дзе Бутс Компани ПЛС Терапевтические средства

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ВОЮЦКИЙ С.С. Курс коллоидной химии. - М.: Химия, 1975, с.12-13, 395-398. КЕЛЬЦЕВ Н.В. Основы адсорбционной техники. - М.: Химия, 1984, с.48, таблица 2-6. ДЫТНЕРСКИЙ Ю.И. Процессы и аппараты химической технологии. - М.: Химия, 1995, т.2, с.43 и 188. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2685294C1 (ru) * 2018-05-10 2019-04-17 Общество с ограниченной ответственностью "ДИНОН" (ООО "ДИНОН") Поглотитель, способ его приготовления (варианты) и способ удаления диоксида углерода из газовых смесей

Also Published As

Publication number Publication date
AU2006325658A1 (en) 2007-06-21
EP1968542A4 (en) 2010-06-02
CA2633266C (en) 2011-08-02
IL191804A0 (en) 2008-12-29
JP2009519326A (ja) 2009-05-14
HK1126671A1 (en) 2009-09-11
NO339674B1 (no) 2017-01-23
AU2006325658B2 (en) 2010-04-08
BRPI0619868A2 (pt) 2011-10-25
ZA200806138B (en) 2009-11-25
CA2633266A1 (en) 2007-06-21
BRPI0619868A8 (pt) 2016-06-07
ES2429097T3 (es) 2013-11-13
NZ569813A (en) 2011-07-29
CN101330904B (zh) 2012-04-18
RU2008129041A (ru) 2010-01-27
EP1968542A1 (en) 2008-09-17
EP1968542B1 (en) 2013-08-14
NO20083151L (no) 2008-09-05
WO2007069874A1 (en) 2007-06-21
US20080292702A1 (en) 2008-11-27
CN101330904A (zh) 2008-12-24

Similar Documents

Publication Publication Date Title
RU2403013C2 (ru) Твердая дисперсия, содержащая активный ингредиент с низкой температурой плавления, и содержащая ее таблетка для перорального введения
KR101812508B1 (ko) 폴리머 담체 조성물을 포함하는 약제 제형
TWI673051B (zh) 恩雜魯它脈（ｅｎｚａｌｕｔａｍｉｄｅ）之調和物
TWI342221B (en) Solid pharmaceutical dosage form
JP6666490B2 (ja) Ｃｇｒｐ活性化合物の錠剤製剤
TW200529803A (en) Extrusion process for forming chemically stable drug multiparticulates
TW200302740A (en) Immediate release dosage forms containing solid drug dispersions
WO2005073286A1 (ja) 多孔質セルロース凝集体及びその成型体組成物
JP2010540547A (ja) アリスキレンおよびバルサルタンのガレヌス製剤
KR20130041144A (ko) 데페라시록스의 경구투여용 제제
WO2010092925A1 (ja) 固体分散体とその医薬組成物、並びにそれらの製造方法
JP5209876B2 (ja) 速崩壊性錠剤及びその製造方法
KR20090047310A (ko) 덱시부프로펜을 함유하는 다층정제
KR20000069356A (ko) 급속방출식 약물전달 제형
EP4132472B1 (en) Oleyl phosphocholine containing granulates
CN112168796A (zh) 双相缓释系统控制释放的药物缓释制剂及其制备方法
MX2008007665A (en) Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same
Patel Design, Development, Evaluation and Optimization of Antiulcer Delayed Release Tablets
WO2006047067A1 (en) Tablets comprising a poorly compressible active agent and tocopherol polyethyleneglycol succinate (tpgs)
CN115212173A (zh) 一种盐酸氨溴索球形缓释微粒、制备方法及用途
HK1126671B (en) Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20110420

PD4A Correction of name of patent owner
MM4A The patent is invalid due to non-payment of fees

Effective date: 20171219